Doctors investigate bleeding risk in stroke patients with hidden brain condition
NCT ID NCT05565144
Summary
This study looked back at 15 stroke patients who had signs of a brain condition called cerebral amyloid angopathy (CAA) on their MRI scans. All patients received a standard clot-busting drug (IV thrombolysis). Researchers wanted to see if having CAA made these patients more likely to have brain bleeding after treatment or to have a worse recovery when leaving the hospital.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.